Drug Master Files for: Specgx Llc
✉ Email this page to a colleague
Specgx Llc Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
10123 | I | II | 3/9/1993 | SPECGX LLC | ZICONOTIDE (SNX-111), CODE 8068 |
10128 | A | II | 3/15/1993 | SPECGX LLC | FENTANYL CITRATE (NEW PROCESS) |
11345 | A | II | 2/10/1995 | SPECGX LLC | MEPERIDINE HYDROCHLORIDE, USP |
11421 | A | II | 3/31/1995 | SPECGX LLC | NALBUPHINE HYDROCHLORIDE (LOW BETA EPIMER) CODE 3310 |
12052 | I | II | 7/18/1996 | SPECGX LLC | LEUPROLIDE ACETATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information